First Migraine Prevention Drug Wins EU Approval
First Migraine Prevention Drug Wins EU Approval
GALWAY, IRELAND--August 14, 2018--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The first-ever migraine prevention drug in Europe has been approved by the European Medicine Agency (EMA) and the European Commission (EC).
Within this article: Details drug approval, developers, potential markets and value
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
